# MARKSANS share price, delivery % and history — Marksans Pharma Limited

> Delivery percentage for Marksans Pharma Limited (MARKSANS) against its own history, with 5,174 sessions of split-adjusted NSE data from 2005 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/MARKSANS

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 322.3 INR (-5.97% on the day), 2026-09-30
- Delivery: 48.45% of volume taken to demat (20-day average 37.99%)
- Volume: 32.53L shares, turnover ₹104.9Cr
- Relative volume: 1.24× of its own 20-day average

## Technicals

- RSI(14): 48.59
- ATR(14): 14.64
- SMA 50: 307.71, SMA 200: 227.27
- 52-week range: 155 – 350.95 (-8.16% from the high)

## Performance

- 1 week -7.28%, 1 month 0.22%, 3 months 20.62%
- 6 months 97.63%, 1 year 88.13%

## Delivery percentage

- Latest: 48.45% (2026-09-30)
- 20-day average: 37.99%
- 1-year average: 41.88%
- Percentile against its own history: 64th
- Range: 10.01% – 100% across 1,728 sessions with a reading

Over the last 20 sessions MARKSANS settled 38.0% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 41.9%, so recent sessions are running 3.9 points lower than usual. The latest session ranks higher than 64% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 14,605.5 crore
- P/E (TTM): 28.02 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 11.5 INR, split-adjusted to match the price series
- Revenue growth: 35.61% YoY, -1.79% QoQ
- Profit growth: 173.89% YoY, 6.96% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 18.26% | 25.02% |
| 3y | 18.25% | 23.67% |
| 4y | 19.11% | 29.67% |
| 5y | 17.87% | 15.67% |
| 6y | 17.41% | 23.4% |
| 7y | 17.76% | 31.17% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 641.9 | 528.4 | 124.6 | 97.8 | 2.13 | 15.23% |
| 2024-12-31 | 681.8 | 566.4 | 143.3 | 105.1 | 2.31 | 15.41% |
| 2025-03-31 | 70.8 | 60.9 | 11.6 | 9.1 | 2 | 12.81% |
| 2025-06-30 | 620 | 549 | 76.6 | 58.2 | 1.29 | 9.39% |
| 2025-09-30 | 720.4 | 608.6 | 133.3 | 99.1 | 2.17 | 13.76% |
| 2025-12-31 | 754.4 | 623.9 | 150.6 | 113.7 | 2.5 | 15.07% |
| 2026-03-31 | 856.1 | 691.3 | 200 | 149 | 3.27 | 17.41% |
| 2026-06-30 | 840.8 | 659.6 | 206.6 | 159.4 | 3.47 | 18.96% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 43.87%
- Public: 56.13%
- FII: 17.47%, DII: 6.19%
- Promoter shares pledged: 0%

## Recent filings

- 2026-08-20: dividend
- 2026-08-12: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_185621_12082026144748_iXBRL_WEB.html
- 2026-07-20: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1696395_20072026103809_WEB.xml
- 2026-05-26: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_161291_26052026163520_iXBRL_WEB.html
- 2026-04-10: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1648616_10042026022024_WEB.xml
- 2026-02-05: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_140464_05022026164615_iXBRL_WEB.html
- 2026-01-13: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1669180_19052026025021_WEB.xml
- 2025-11-13: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_127579_13112025203258_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 119 events are indexed for this instrument.

## About the instrument

- Listed: 2005-11-14 — latest session 2026-09-30 (5,174 sessions)
- ISIN: INE750C01026
- Series: EQ
- Liquidity rank: #332 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/MARKSANS.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.